We have shown that chronic treatment of Tg2576 AD mice and an aged rat model with bryostatin, a selective PKCε activator, dramatically reduces the levels of Aβ, recovers the loss of neurotrophic activity and synapses, and enhances cognitive function [18], [19]. This evidence concerns the gene PRKCE and Alzheimer disease.